MedTrace Logo

Accuracy of CGM in the ICU, Compared to Standard of Care

NCT04352907 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2022-06-02

No results posted yet for this study

Summary

To determine the performance of the Dexcom CGM device in comparison to arterial glucose samples.

Conditions

Interventions

DEVICE

Continuous Glucose Sensor

Continuous glucose sensor results will be compared with arterial glucose samples

Sponsors & Collaborators

  • DexCom, Inc.

    collaborator INDUSTRY

  • University of British Columbia

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-11-06
Primary Completion
2022-09-30
Completion
2022-09-30
FDA Device
Yes

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04352907 on ClinicalTrials.gov